Cardinal Health 2011 Annual Report Download - page 24

Download and view the complete annual report

Please find page 24 of the 2011 Cardinal Health annual report below. You can navigate through the pages in the report by either clicking on the pages listed below, or by using the keyword search tool below to find specific information within the annual report.

Page out of 122

  • 1
  • 2
  • 3
  • 4
  • 5
  • 6
  • 7
  • 8
  • 9
  • 10
  • 11
  • 12
  • 13
  • 14
  • 15
  • 16
  • 17
  • 18
  • 19
  • 20
  • 21
  • 22
  • 23
  • 24
  • 25
  • 26
  • 27
  • 28
  • 29
  • 30
  • 31
  • 32
  • 33
  • 34
  • 35
  • 36
  • 37
  • 38
  • 39
  • 40
  • 41
  • 42
  • 43
  • 44
  • 45
  • 46
  • 47
  • 48
  • 49
  • 50
  • 51
  • 52
  • 53
  • 54
  • 55
  • 56
  • 57
  • 58
  • 59
  • 60
  • 61
  • 62
  • 63
  • 64
  • 65
  • 66
  • 67
  • 68
  • 69
  • 70
  • 71
  • 72
  • 73
  • 74
  • 75
  • 76
  • 77
  • 78
  • 79
  • 80
  • 81
  • 82
  • 83
  • 84
  • 85
  • 86
  • 87
  • 88
  • 89
  • 90
  • 91
  • 92
  • 93
  • 94
  • 95
  • 96
  • 97
  • 98
  • 99
  • 100
  • 101
  • 102
  • 103
  • 104
  • 105
  • 106
  • 107
  • 108
  • 109
  • 110
  • 111
  • 112
  • 113
  • 114
  • 115
  • 116
  • 117
  • 118
  • 119
  • 120
  • 121
  • 122

CARDINAL HEALTH, INC. AND SUBSIDIARIES
GAAP / NON-GAAP RECONCILIATION
 GAAP




related
costs






Other

costs
Gain on

CareFusion


GAAP

Amount $1,514 $16 $23 $9 $6 $10 — $1,577
Growth rate 16% 14%

Amount $2.74 $0.03 $0.06 $0.02 $0.02 $0.02 ($0.21) $2.67
Growth rate 69% 20%
 GAAP




related
costs






Other

costs
Gain on

CareFusion


GAAP

Amount $1,307 $91 $8 $29 ($62) $11 — $1,383
Growth rate 1 % (2)%

Amount $1.62 $0.16 $0.02 $0.09 ($0.11) $0.56 ($0.12) $2.22
Growth rate (23)% (2)%
 GAAP




related
costs






Other

costs
Gain on

CareFusion


GAAP

Amount $1,287 $105 $3 $14 $5 $5 — $1,419
Growth rate (8)% (1)%

Amount $2.10 $0.21 — ($0.07) $0.01 $0.01 — $2.26
Growth rate (10)% (8)%
The sum of the components may not equal the total due to rounding.
Beginning in scal 2012, we will use new non-GAAP denitions. The new denitions exclude amortization of acquisition-related intangible assets in addition to the items currently
excluded. All non-GAAP measures shown are calculated under the historical denition.
(in millions, except per Common Share amounts)
Important notice regarding forward-looking statements
This annual report contains forward-looking statements addressing expectations, prospects, estimates and other matters that are dependent upon future events or developments.
These statements may be identied by words such as “expect,” “anticipate,” “intend,” “plan,” “believe,” “will,” “should,” “could,” “would,” “project,” “continue,” and similar expressions, and
include statements reecting future results or guidance, statements of outlook and expense accruals. These matters are subject to risks and uncertainties that could cause actual results to
dier materially from those projected, anticipated or implied. These risks and uncertainties include (but are not limited to) uncertainties related to demand for Cardinal Health’s products
and services; uncertainties relating to Cardinal Health’s ability to retain customers and employees of acquired businesses, including Kinray, Yong Yu and P4 Healthcare, and to achieve
the expected benets from the acquired businesses; uncertainties due to government health care reform including the federal health care reform legislation; competitive pressures in
Cardinal Health’s various lines of business; the loss of one or more key customer or supplier relationships or changes to the terms of those relationships; the timing of generic and branded
pharmaceutical introductions and the frequency or rate of branded pharmaceutical price appreciation or generic pharmaceutical price deation; changes in the distribution patterns or
reimbursement rates for health care products and/or services; the eects of any investigation by any regulatory authority , including with respect to compliance with the Foreign Corrupt
Practices Act. Cardinal Health is subject to additional risks and uncertainties described in Cardinal Health’s Form 10-K, Form 10-Q and Form 8-K reports (including all amendments to those
reports) and exhibits to those reports. This annual report reects management’s views as of Aug. 25, 2011. Except to the extent required by applicable law, Cardinal Health undertakes no
obligation to update or revise any forward-looking statement.
